International Assets Investment Management LLC Has $402,000 Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

International Assets Investment Management LLC boosted its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 7.3% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,929 shares of the financial services provider’s stock after purchasing an additional 200 shares during the quarter. International Assets Investment Management LLC’s holdings in iShares Biotechnology ETF were worth $402,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of IBB. Future Financial Wealth Managment LLC bought a new position in shares of iShares Biotechnology ETF in the 1st quarter valued at $27,000. Bbjs Financial Advisors LLC acquired a new stake in iShares Biotechnology ETF in the second quarter valued at approximately $31,000. Pacifica Partners Inc. grew its stake in shares of iShares Biotechnology ETF by 118.2% during the first quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock worth $33,000 after buying an additional 130 shares during the last quarter. Crewe Advisors LLC increased its holdings in shares of iShares Biotechnology ETF by 42.9% during the fourth quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock worth $35,000 after buying an additional 78 shares in the last quarter. Finally, YHB Investment Advisors Inc. bought a new position in shares of iShares Biotechnology ETF in the 1st quarter valued at $37,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.1 %

Shares of IBB opened at $148.17 on Friday. iShares Biotechnology ETF has a 12-month low of $111.83 and a 12-month high of $150.17. The business has a 50-day simple moving average of $143.44 and a two-hundred day simple moving average of $137.63.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.